OstiSense Biosensor in Bruxism Reduction - A Clinical Study

Bruxism, Sleep Clinical Trial

Official title:

OstiSense Biosensor in Bruxism Reduction - A Clinical Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03749928
• Other study ID #: P0533276
• Status: Withdrawn
• Phase: N/A
• Start date: December 2021
• Est. completion date: December 2022

Study information

• Verified date: March 2022
• Source: University of California, San Francisco
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The overall objective of the clinical studies with the OstiSense biosensor tool will be to evaluate whether the use of the OstiSense biosensor tool significantly reduces the number of sleep bruxism events per night as well as the duration of those events for patients with bruxism.The product under investigation is the OstiSense biosensor with biofeedback for bruxism therapy. The sensor is integrated in a night-guard like device and registers the pressure created during a bruxism episode. If a predetermined pressure threshold is exceeded, the integrated vibration tool will be activated, and the vibrations will/should remind the wearer to stop clenching his jaws and relax his facial muscles. Due to this feedback, the number of bruxism episodes as well as clenching time per episode should be reduced. The sensor also identifies the time of grinding and the sleep stage of the patient.

Description:

Pilot Study: 30 subjects will be recruited for this pilot study. An oral exam will be performed to check for gingiva and tooth conditions as well as fulfilling inclusion and exclusion criteria as described below. Subjects will be randomly assigned to an active treatment or a control group. OstiSense biosensor feed back tool (night guards) will be delivered to the participant. First patient impressions about wearing comfort will be evaluated, chair side. Then the investigators will test the efficiency of the OstiSense biosensor feedback tool in reduction of numbers of bruxism episodes and reduction of the duration of bruxism episodes (primary outcome). These data will be collected also in order to achieve information for a sample size calculation for a larger subsequent clinical trial. The investigators will collect information about self-reported (or reported by sleeping partners in SB) reduced frequency of bruxism episodes. In addition, self-reported reduction in pain (facial pain, myofascial headache) (secondary outcome) is of interest. Visual pain scales and pain questionnaires will be used as validated instruments for subjective pain assessment. Active Treatment Group: Participants will be instructed to wear the biofeedback tool during the night/sleep. They will wear the biofeedback tool for 1 week with biofeedback turned off to record baseline activity. At the 1-week recall, the investigators will check for any comfort issues and will confirm accurate data recording. For 3 more weeks the biofeedback will stay turned off to collect further baseline data. At the next recall (4-week recall) participants will be interviewed about any wear issues and will be asked to fill out the same questionnaire as used in phase 1 of the pilot study. The biofeedback mechanism will then be turned on (battery insertion). During this meeting subjects will be instructed to test the vibration mechanism by increasing their bite force until vibration occurs, and then to relax their muscles so that vibration stops. Subjects will be asked to repeat this procedure several times to get familiar with the active device and also to learn to relax their muscles when the feedback occurs during night bruxism.. Participants will wear the tool with biofeedback turned on during the night/sleep for 8 more weeks. They will be asked to return for a check after the first week (5-week recall) of the 8 weeks to identify any wear issues while the tool is turned on, and for checking the data recording function. At the end of 8 weeks, participants will be invited for a final recall visit 12-week recall). The same questionnaire will be provided, and feedback questions will be asked. All data about bruxism episodes will be collected from the smart device. Control Group: Participants in the control group will be treated, asked for feedback and receive questionnaires identical to the subjects in the active treatment group. The only difference will be that the biofeedback mechanism in the biofeedback night guard tool will always stay turned off. At the 1-week recall the investigators will check for any comfort issues and will confirm accurate data recording. After three weeks the investigators will again check on the participant, will identify any wear issues, ask for feedback and will check the data recording function (4-week recall). At the end of additional 8 weeks participants will be invited for a final recall visit (12-week recall). The questionnaire will be provided, and feedback questions will be asked. Data from the smart device about bruxism episodes will be collected.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2022
• Est. primary completion date: September 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• age 18 to 65 years, in good general health
• the occlusion is stable with at least 8 lower teeth (including several lower front teeth)
• willing to comply with all study procedures and protocols
• must be able to read and understand English
• have an understanding of the study
• able to provide written informed consent in English
• willing to sign the "Authorization for Release of Personal Health Information and Use of Personally Unidentified Study Data for Research" form; data will only be used for research.

Exclusion Criteria:

• having acute temporo mandibular joint pain or a history of acute temporo mandibular joint pain
• having used a biofeedback tool for bruxism reduction before
• subjects not having a smart phone device
• subjects not willing to use their smart phone device for data collection related to their bruxism
• heavily crowed lower teeth (difficult to integrate a night guard)
• wearing complete dentures
• show evidence of extremely poor oral hygiene
• subjects at extreme high caries risk
• subjects with pacemakers
• subjects suffering from systemic diseases, significant past or medical history with conditions that may affect oral health or oral flora (i.e. diabetes, HIV, heart conditions that require antibiotic prophylaxis),
• taking medications that may affect the oral flora or salivary flow (e.g. antibiotic use in the past three months, drugs associated with dry mouth / xerostomia [extreme high caries risk])
• other conditions that may decrease the likelihood of adhering to study protocol
• subjects who will leave the area and are unable to complete the study

Related Conditions & MeSH terms

• Bruxism
• Bruxism, Sleep
• Sleep Bruxism

Intervention

Device:
• OstiSense biosensor - active
The activated biofeedback back night guard will be used to reduce sleep bruxism
• OstiSensor biosensor - not activated
A not-activated night guard will be used as control device

Locations

Country	Name	City	State
United States	UCSF School of Dentistry - Dental Offices in Bay Area	San Francisco	California

Sponsors (1)

Lead Sponsor	Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

References & Publications (23)

Bowley JF, Stockstill JW, Pierce CJ. Reliability and validity of instrumentation used to record nocturnal clenching and/or grinding. J Orofac Pain. 1993 Fall;7(4):378-85. — View Citation

Carra MC, Huynh N, Lavigne G. Sleep bruxism: a comprehensive overview for the dental clinician interested in sleep medicine. Dent Clin North Am. 2012 Apr;56(2):387-413. doi: 10.1016/j.cden.2012.01.003. Review. — View Citation

Cassisi JE, McGlynn FD, Belles DR. EMG-activated feedback alarms for the treatment of nocturnal bruxism: current status and future directions. Biofeedback Self Regul. 1987 Mar;12(1):13-30. Review. — View Citation

de la Hoz-Aizpurua JL, Díaz-Alonso E, LaTouche-Arbizu R, Mesa-Jiménez J. Sleep bruxism. Conceptual review and update. Med Oral Patol Oral Cir Bucal. 2011 Mar 1;16(2):e231-8. Review. — View Citation

Foster PS. Use of the Calmset 3 biofeedback/relaxation system in the assessment and treatment of chronic nocturnal bruxism. Appl Psychophysiol Biofeedback. 2004 Jun;29(2):141-7. — View Citation

Gavish A, Halachmi M, Winocur E, Gazit E. Oral habits and their association with signs and symptoms of temporomandibular disorders in adolescent girls. J Oral Rehabil. 2000 Jan;27(1):22-32. — View Citation

Gu W, Yang J, Zhang F, Yin X, Wei X, Wang C. Efficacy of biofeedback therapy via a mini wireless device on sleep bruxism contrasted with occlusal splint: a pilot study. J Biomed Res. 2015 Apr;29(2):160-8. doi: 10.7555/JBR.28.20130145. Epub 2014 Nov 18. — View Citation

Hublin C, Kaprio J, Partinen M, Koskenvuo M. Sleep bruxism based on self-report in a nationwide twin cohort. J Sleep Res. 1998 Mar;7(1):61-7. — View Citation

Ilovar S, Zolger D, Castrillon E, Car J, Huckvale K. Biofeedback for treatment of awake and sleep bruxism in adults: systematic review protocol. Syst Rev. 2014 May 2;3:42. doi: 10.1186/2046-4053-3-42. — View Citation

Jagger R. The effectiveness of occlusal splints for sleep bruxism. Evid Based Dent. 2008;9(1):23. doi: 10.1038/sj.ebd.6400569. — View Citation

Klasser GD, Greene CS, Lavigne GJ. Oral appliances and the management of sleep bruxism in adults: a century of clinical applications and search for mechanisms. Int J Prosthodont. 2010 Sep-Oct;23(5):453-62. Review. — View Citation

Koyano K, Tsukiyama Y, Ichiki R, Kuwata T. Assessment of bruxism in the clinic. J Oral Rehabil. 2008 Jul;35(7):495-508. doi: 10.1111/j.1365-2842.2008.01880.x. Review. — View Citation

Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil. 2008 Jul;35(7):476-94. doi: 10.1111/j.1365-2842.2008.01881.x. Review. — View Citation

Lobbezoo F, Ahlberg J, Glaros AG, Kato T, Koyano K, Lavigne GJ, de Leeuw R, Manfredini D, Svensson P, Winocur E. Bruxism defined and graded: an international consensus. J Oral Rehabil. 2013 Jan;40(1):2-4. doi: 10.1111/joor.12011. Epub 2012 Nov 4. — View Citation

Lobbezoo F, van der Zaag J, van Selms MK, Hamburger HL, Naeije M. Principles for the management of bruxism. J Oral Rehabil. 2008 Jul;35(7):509-23. doi: 10.1111/j.1365-2842.2008.01853.x. Review. — View Citation

Macedo CR, Macedo EC, Torloni MR, Silva AB, Prado GF. Pharmacotherapy for sleep bruxism. Cochrane Database Syst Rev. 2014 Oct 23;(10):CD005578. doi: 10.1002/14651858.CD005578.pub2. Review. — View Citation

Macedo CR, Silva AB, Machado MA, Saconato H, Prado GF. Occlusal splints for treating sleep bruxism (tooth grinding). Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005514. Review. — View Citation

Molina OF, dos Santos J Jr, Nelson SJ, Grossman E. Prevalence of modalities of headaches and bruxism among patients with craniomandibular disorder. Cranio. 1997 Oct;15(4):314-25. — View Citation

Rivera-Morales WC, McCall WD Jr. Reliability of a portable electromyographic unit to measure bruxism. J Prosthet Dent. 1995 Feb;73(2):184-9. — View Citation

Rosar JV, Barbosa TS, Dias IOV, Kobayashi FY, Costa YM, Gavião MBD, Bonjardim LR, Castelo PM. Effect of interocclusal appliance on bite force, sleep quality, salivary cortisol levels and signs and symptoms of temporomandibular dysfunction in adults with sleep bruxism. Arch Oral Biol. 2017 Oct;82:62-70. doi: 10.1016/j.archoralbio.2017.05.018. Epub 2017 May 27. — View Citation

Rugh JD, Johnson RW. Temporal analysis of nocturnal bruxism during EMG feedback. J Periodontol. 1981 May;52(5):263-5. — View Citation

Svensson P, Jadidi F, Arima T, Baad-Hansen L, Sessle BJ. Relationships between craniofacial pain and bruxism. J Oral Rehabil. 2008 Jul;35(7):524-47. doi: 10.1111/j.1365-2842.2008.01852.x. Review. — View Citation

Wang LF, Long H, Deng M, Xu H, Fang J, Fan Y, Bai D, Han XL. Biofeedback treatment for sleep bruxism: a systematic review. Sleep Breath. 2014 May;18(2):235-42. doi: 10.1007/s11325-013-0871-y. Epub 2013 Jun 12. Review. — View Citation

* Note: There are 23 references in all — Click here to view all references

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in frequency of bruxism episodes	Evaluating how efficient the OstiSense biosensor tool is in changing the number of bruxism episodes	8 weeks
Primary	Change in duration of bruxism episodes	Evaluating how efficient the OstiSense biosensor tool is in changing the duration of bruxism episodes	8 weeks
Secondary	Self-reported change in frequency of bruxism episodes	Self-reported (or reported by sleeping partners in SB) change in frequency of bruxism episodes	8 weeks
Secondary	Self-reported change in pain - change in pain level marked on a visual pain scale	Self-reported change in pain (facial pain, myofascial headache) assessed using a visual pain scale with 6 different pain levels indicated by 6 different smileys (from happy smiling to crying) and a pain severity scale from 0 to 10, which includes the smiley faces, with 0 as no pain, 1-2 slight pain, 3-4 mild, 5-6 moderate, 7-8 severe and 9-10 horrible pain	8 weeks
Secondary	Self-reported change in pain - change in yes/no answers on a pain questionnaire	Self-reported change in pain (facial pain, myofascial headache) using a pain questionnaires requiring yes and no answers to questions	8 weeks